Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127016331 | 12701633 | 1 | I | 2004 | 20160822 | 20160831 | 20160831 | EXP | US-ASTRAZENECA-2016SE91147 | ASTRAZENECA | 62.00 | YR | M | Y | 79.40000 | KG | 20160831 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127016331 | 12701633 | 1 | SS | METOPROLOL ER | METOPROLOL SUCCINATE | 1 | Oral | 54800 | MG | UNKNOWN | 0 | 25 | MG | MODIFIED-RELEASE TABLET | QD | ||||
| 127016331 | 12701633 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 87680 | MG | UNKNOWN | 0 | 40 | MG | TABLET | QD | ||||
| 127016331 | 12701633 | 3 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, 2 PUFFS TWICE DAILY | UNKNOWN | 21929 | |||||||||
| 127016331 | 12701633 | 4 | SS | CHEMOTHERAPY | UNSPECIFIED INGREDIENT | 1 | Unknown | U | 0 | ||||||||||
| 127016331 | 12701633 | 5 | SS | RADIATION THERAPY | RADIATION THERAPY | 1 | Unknown | U | 0 | ||||||||||
| 127016331 | 12701633 | 6 | C | OXYGEN. | OXYGEN | 1 | Nasal | UNKNOWN | 0 | 2 | L | QD | |||||||
| 127016331 | 12701633 | 7 | C | DIATELAZAM HCL ER | 2 | Oral | UNKNOWN | 0 | 300 | MG | QD | ||||||||
| 127016331 | 12701633 | 8 | C | BAYER LOW DOSE ASPIRIN | 2 | Oral | UNKNOWN | 0 | 81 | MG | QD | ||||||||
| 127016331 | 12701633 | 9 | C | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | AS NEEDED UP TO 6 PUFFS A DAY | UNKNOWN | 0 | |||||||||
| 127016331 | 12701633 | 10 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 5/325MG UP TO TWICE DAILY | UNKNOWN | 0 | |||||||||
| 127016331 | 12701633 | 11 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | Oral | AS NEEDED | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127016331 | 12701633 | 1 | Cardiac disorder |
| 127016331 | 12701633 | 2 | Blood cholesterol increased |
| 127016331 | 12701633 | 3 | Chronic obstructive pulmonary disease |
| 127016331 | 12701633 | 6 | Chronic obstructive pulmonary disease |
| 127016331 | 12701633 | 7 | Cardiac disorder |
| 127016331 | 12701633 | 8 | Cardiac disorder |
| 127016331 | 12701633 | 9 | Chronic obstructive pulmonary disease |
| 127016331 | 12701633 | 10 | Pain in extremity |
| 127016331 | 12701633 | 11 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127016331 | 12701633 | HO |
| 127016331 | 12701633 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127016331 | 12701633 | Arthralgia | |
| 127016331 | 12701633 | Body height decreased | |
| 127016331 | 12701633 | Cartilage injury | |
| 127016331 | 12701633 | Chest pain | |
| 127016331 | 12701633 | Gait disturbance | |
| 127016331 | 12701633 | Headache | |
| 127016331 | 12701633 | Hepatic cancer | |
| 127016331 | 12701633 | Lung disorder | |
| 127016331 | 12701633 | Lung neoplasm malignant | |
| 127016331 | 12701633 | Myocardial infarction | |
| 127016331 | 12701633 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127016331 | 12701633 | 1 | 2004 | 0 | ||
| 127016331 | 12701633 | 2 | 2004 | 0 | ||
| 127016331 | 12701633 | 3 | 201608 | 0 | ||
| 127016331 | 12701633 | 7 | 2010 | 0 | ||
| 127016331 | 12701633 | 9 | 1996 | 0 |